Secondary – Neftaly Hospital

Neftaly Managing Consent for Secondary Data Use

Ethical, Transparent, and Patient-Centered Data Governance

As healthcare systems increasingly rely on data to improve outcomes, drive research, and enhance operations, secondary data use has become essential. However, using patient data beyond its original intent requires more than just compliance — it demands transparency, trust, and control.

Neftaly’s Consent Management for Secondary Data Use is a secure, customizable platform that empowers organizations to manage patient permissions ethically and efficiently, while giving individuals real visibility and control over how their data is used.

???? What is Secondary Data Use?

Secondary data use refers to the use of patient health information for purposes beyond direct clinical care, such as:

Medical and academic research
Population health analytics
Quality improvement initiatives
Public health reporting
AI and machine learning model training

These uses can drive innovation — but only with proper, informed consent.

???? Neftaly’s Solution: Consent with Clarity

✅ Granular Consent Options

Allow patients to give or withhold consent for specific types of secondary data use — from research participation to anonymized data sharing for AI development.

✅ Dynamic Consent Management

Enable patients to update their choices anytime via a user-friendly portal, with clear explanations and no hidden fine print.

✅ Audit-Ready Tracking

Neftaly provides a full audit trail of consent activity, including timestamps, consent types, and any changes made — ensuring legal defensibility and regulatory alignment.

✅ Integration-Ready

Seamlessly integrates with EHRs, data lakes, and research platforms to enforce consent rules automatically at the data access level.

✅ Patient-Centered Design

Consent interfaces are built with health literacy in mind — simple language, multilingual support, and accessible formats for all users.

???? Benefits for Health Systems & Patients

Build Trust: Transparent consent builds stronger patient relationships and improves participation in research initiatives.
Stay Compliant: Stay ahead of evolving privacy regulations (HIPAA, GDPR, national/local frameworks).
Improve Efficiency: Automate data access permissions based on consent status.
Support Innovation: Enable ethical secondary use of data while respecting individual preferences.

???? Use Cases

Biobank and clinical trial consent tracking
AI model training on de-identified patient records
Opt-in/opt-out for public health or academic studies
Consent for sharing with third-party analytics vendors

????️ Security & Privacy First

Neftaly uses end-to-end encryption, role-based access controls, and fine-grained permission layers to ensure that consent choices are enforced without compromise.

???? Always Up-to-Date, Always Under Control

Consent isn’t a one-time checkbox. Neftaly supports ongoing, dynamic consent — giving patients full visibility and control over how their data evolves with them.

???? Start Ethical Data Use Today

Neftaly helps healthcare organizations unlock the full value of data — responsibly, transparently, and in partnership with the people it belongs to.

???? Schedule a Demo | ???? Download the Whitepaper | ???? Visit sayprohealth.com/consent

25/08/2025

Neftaly Use of Digital Therapeutics for Stroke Secondary Prevention

he Neftaly Multimodal Pain Management Strategy outlines an integrated approach that combines multiple therapies targeting different pain pathways and factors. This strategy aims to optimize pain relief, improve function, and minimize side effects by using complementary treatments in synergy.

1. Rationale for Multimodal Pain Management

Pain is complex and involves multiple biological, psychological, and social dimensions.
Single-modality treatments often provide incomplete relief.
Combining pharmacologic and non-pharmacologic therapies can enhance efficacy and reduce reliance on high-risk medications like opioids.
Tailored, multimodal approaches improve patient outcomes and satisfaction.

2. Components of the Multimodal Strategy

2.1 Pharmacologic Therapies

Non-opioid analgesics: NSAIDs, acetaminophen
Adjuvant medications: Antidepressants, anticonvulsants for neuropathic pain
Opioids: Reserved for carefully selected patients, lowest effective dose, short duration
Topical agents: Lidocaine patches, capsaicin cream

2.2 Physical Therapies

Therapeutic exercises for strength, flexibility, and endurance
Manual therapy and mobilization techniques
Posture and ergonomics training
Modalities such as heat, cold, ultrasound, and electrical stimulation

2.3 Psychological Interventions

Cognitive-behavioral therapy (CBT) to address pain perception and coping
Mindfulness and relaxation techniques
Biofeedback and stress management

2.4 Complementary and Alternative Therapies

Acupuncture
Massage therapy
Chiropractic care
Yoga and tai chi

3. Implementation Steps

3.1 Comprehensive Assessment

Thorough evaluation of pain type, severity, and impact
Psychological and social screening
Functional status assessment

3.2 Individualized Treatment Planning

Develop a personalized plan combining multiple modalities
Engage the patient in goal setting and shared decision-making

3.3 Coordinated Care

Multidisciplinary team involvement including physicians, physiotherapists, psychologists, and other specialists
Clear communication channels among providers

4. Monitoring and Evaluation

Regular assessment of pain levels, functional improvement, and treatment side effects
Use of standardized tools for tracking progress
Flexibility to adjust modalities and dosages based on response

5. Benefits of Multimodal Pain Management

Enhanced pain control through synergistic effects
Reduced medication doses and related adverse events
Improved physical and psychological function
Increased patient satisfaction and quality of life

6. Challenges and Considerations

Coordination among multiple providers
Patient adherence to complex regimens
Access to multidisciplinary resources
Insurance coverage and cost implications

7. Conclusion

The Neftaly Multimodal Pain Management Strategy represents a comprehensive, evidence-based approach to pain care that addresses the multifaceted nature of pain. By integrating various therapeutic modalities, this strategy maximizes pain relief, supports function, and minimizes risks, thereby enhancing patient outcomes and overall well-being.

21/08/2025

Neftaly Use of De-identified Data for Secondary Research

public trust.

Would you like assistance with:

A Data Management Plan template tailored to POPIA and de-identification?
Ethics review submission language for de-identified secondary research?
A community engagement blueprint for responsible secondary use?

Happy to help you operationalize any of these next steps!

18/08/2025

Neftaly Inpatient statin use and secondary stroke prevention

Introduction

Stroke survivors face a substantial risk of recurrent cerebrovascular events, making secondary prevention a critical aspect of stroke care. Among various interventions, statin therapy has emerged as a cornerstone in reducing recurrent ischemic stroke and improving long-term outcomes.

At Neftaly, we emphasize the importance of timely initiation and adherence to statin treatment during the inpatient stay as part of comprehensive secondary prevention strategies.

The Role of Statins in Secondary Stroke Prevention

Statins (HMG-CoA reductase inhibitors) lower low-density lipoprotein cholesterol (LDL-C) and have pleiotropic effects, including anti-inflammatory and plaque-stabilizing properties. Their benefits in stroke survivors include:

Reducing the risk of recurrent ischemic stroke
Lowering the incidence of major cardiovascular events such as myocardial infarction
Improving endothelial function and cerebral blood flow
Decreasing systemic inflammation contributing to atherosclerosis progression

Evidence Supporting Inpatient Statin Initiation

Landmark trials such as SPARCL demonstrated that high-intensity statins significantly reduce stroke recurrence risk.
Early initiation of statins during the hospital stay is associated with better compliance and improved outcomes compared to delayed or outpatient-only initiation.
Guidelines recommend starting or continuing statins in all eligible patients with ischemic stroke or TIA unless contraindicated.

Challenges in Inpatient Statin Use

Under-prescription due to lack of awareness, clinical inertia, or concerns about adverse effects.
Variability in adherence to guidelines across hospitals and stroke units.
Insufficient monitoring and follow-up post-discharge, leading to treatment discontinuation.
Managing statin therapy in patients with hemorrhagic stroke or complex comorbidities requires careful clinical judgment.

Strategies to Enhance Statin Use for Secondary Prevention

1. Standardized Protocols

Implement stroke unit protocols mandating statin evaluation and initiation for all eligible patients.
Integrate statin prescription into electronic discharge checklists.

2. Multidisciplinary Approach

Engage neurologists, pharmacists, nurses, and rehabilitation teams in medication reconciliation and patient counselling.
Early involvement of clinical pharmacists to optimize statin dosing and manage side effects.

3. Patient Education

Inform patients and caregivers about the benefits and safety of statins.
Address misconceptions and encourage adherence through clear communication.

4. Post-Discharge Follow-Up

Ensure outpatient follow-up for lipid monitoring and therapy adjustment.
Use telehealth and reminder systems to support medication adherence.

Neftaly’s Support for Improving Statin Use in Stroke Care

???? Clinical Training

Workshops and online modules on evidence-based secondary prevention, including statin therapy.
Training on managing statin intolerance and interactions.

???? Quality Improvement Initiatives

Auditing statin prescription rates and identifying barriers.
Providing feedback and best practices to healthcare teams.

???? Decision Support Tools

Implementing clinical decision support systems to prompt statin initiation.
Integration with electronic health records to flag eligible patients.

Conclusion

Statins are a proven, cost-effective intervention for reducing recurrent stroke risk and improving vascular health. Early and consistent inpatient use of statins, combined with ongoing patient support, is vital to successful secondary stroke prevention.

Neftaly is committed to empowering stroke care teams to optimize statin use, improving survival and quality of life for stroke survivors worldwide.